We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$819M
AUM Growth
+$123M
(+18%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
12.29%
Top 10 Holdings %
Top 10 Hldgs %
9.75%
Holding
710
New
168
Increased
162
Reduced
95
Closed
285
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.74M |
| 2 |
McDonald's
MCD
|
+$8.2M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$8.03M |
| 4 |
AGN
Allergan plc
AGN
|
+$7.37M |
| 5 |
Henry Schein
HSIC
|
+$6.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$7.17M |
| 2 |
Lam Research
LRCX
|
+$6.99M |
| 3 |
Electronic Arts
EA
|
+$6.98M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$6.79M |
| 5 |
Hilton Worldwide
HLT
|
+$6.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Technology | 15.05% |
| 3 | Consumer Discretionary | 14.44% |
| 4 | Financials | 11.43% |
| 5 | Consumer Staples | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
InterDigital
IDCC
$6.72B
| $1.34M | 0.16% |
18,200
+15,800
| +658% | +$1.16M |
|
202
Acadia Pharmaceuticals
ACAD
$4.45B
| $1.33M | 0.16% |
+35,403
| New | +$1.15M |
|
203
Willis Towers Watson
WTW
$29.9B
| $1.33M | 0.16% |
8,639
+400
| +5% | +$59.7K |
|
204
Xylem
XYL
$29.7B
| $1.32M | 0.16% |
+21,120
| New | +$1.26M |
|
|
INFO
205
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.32M | 0.16% |
29,935
-14,000
| -32% | -$645K |
|
206
Johnson & Johnson
JNJ
$643B
| $1.31M | 0.16% |
10,100
+2,600
| +35% | +$345K |
|
207
Citigroup
C
$222B
| $1.28M | 0.16% |
17,600
-86,900
| -83% | -$5.93M |
|
|
ALR
208
DELISTED
Alere Inc
ALR
| $1.27M | 0.16% |
25,000
-2,700
| -10% | -$135K |
|
209
United Airlines
UAL
$40.2B
| $1.27M | 0.16% |
20,925
+6,700
| +47% | +$446K |
|
210
Peabody Energy
BTU
$2.83B
| $1.27M | 0.16% |
+43,893
| New | +$1.24M |
|
211
Capri Holdings
CPRI
$1.88B
| $1.26M | 0.15% |
+26,267
| New | +$1.07M |
|
|
CVSA
212
Covista Inc
CVSA
$4.3B
| $1.24M | 0.15% |
34,700
+18,300
| +112% | +$625K |
|
|
ONCE
213
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.24M | 0.15% |
+13,900
| New | +$1.06M |
|
|
B
214
Barrick Mining
B
$61.5B
| $1.24M | 0.15% |
76,880
+57,900
| +305% | +$968K |
|
|
CYBR
215
DELISTED
CyberArk
CYBR
| $1.22M | 0.15% |
+29,800
| New | +$1.26M |
|
|
SYT
216
DELISTED
Syngenta Ag
SYT
| $1.22M | 0.15% |
13,276
-571
| -4% | -$52.6K |
|
|
ENDP
217
DELISTED
Endo International plc
ENDP
| $1.22M | 0.15% |
+142,384
| New | +$1.37M |
|
|
AJRD
218
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.21M | 0.15% |
+34,500
| New | +$929K |
|
|
RHT
219
DELISTED
Red Hat Inc
RHT
| $1.21M | 0.15% |
10,900
-55,100
| -83% | -$5.64M |
|
220
Synopsys
SNPS
$73.5B
| $1.2M | 0.15% |
14,900
-2,500
| -14% | -$194K |
|
|
MIK
221
DELISTED
Michaels Stores, Inc
MIK
| $1.2M | 0.15% |
+55,800
| New | +$1.14M |
|
|
WRK
222
DELISTED
WestRock Company
WRK
| $1.19M | 0.15% |
21,003
+17,400
| +483% | +$993K |
|
223
Twilio
TWLO
$29.5B
| $1.19M | 0.15% |
+39,819
| New | +$1.19M |
|
224
Owens Corning
OC
$11.5B
| $1.18M | 0.14% |
15,299
+1,100
| +8% | +$76.9K |
|
|
TSS
225
DELISTED
Total System Services, Inc.
TSS
| $1.18M | 0.14% |
18,017
+17,100
| +1,865% | +$1.11M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Seven Eight Capital held 710 positions worth $819M, up 18% from $696M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $101M of net new capital in Q3 2017, opening 168 new positions and adding to 162 existing holdings. Its largest new stake was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Constellation Brands, an estimated $6.37M trimmed.
- Seven Eight Capital's largest Q3 2017 buy was Intercept Pharmaceuticals, Inc.: 90,387 shares worth $5.25M.
- Seven Eight Capital added most to McDonald's in Q3 2017, an estimated $8.2M increase.
- Seven Eight Capital's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $6.37M.
- Seven Eight Capital fully exited Nike in Q3 2017, selling an estimated $7.17M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $819M portfolio in Q3 2017.
- Seven Eight Capital opened 168 new positions and closed 285 in Q3 2017.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $819M.
Based on Seven Eight Capital's 13F filing for Q3 2017, filed 16 Oct 2017.